Page 17 - T Cell News Today

Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn't go, tucking into the lungs or other noncancerous tissue and causing toxic side effects.

Cedars-Sinai researchers are working with Axiom Space to test if stem cells can be easily produced and grown aboard the International Space Station.

Researchers compare the adaptive, innate, and humoral immune responses between pregnant and non-pregnant women with COVID-19.

Researchers designed a novel messenger ribonucleic acid (mRNA) vaccine component designated BNT162b4.

Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic...

The new state-of-the-art facility in Bengaluru is creating inroads in T-Cell therapy. We look at Immuneel’s goals and check out the latest on T cells.

Researchers investigate whether SARS-CoV-2 and its variants have evolved to evade CD8+ T cell-mediated immunity.

Pieren, D. K. J., Kuguel, S. G., Rosado, J., Robles, A. G., Rey-Cano, J., Mancebo, C., Esperalba, J., Falcó, V., Buzón, M. J., & Genescà, M. (2023). Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-37559-w, https://www.nature.com/articles/s41467-023-37559-w

The University of Kentucky is taking part in a national COVID vaccine study.

The University of Kentucky is taking part in a national COVID vaccine study.